News

OncoSwab involvement in the Lung Cancer Awareness Month

OncoSwab’s involvment in Lung Cancer Awareness Month November marks Lung Cancer Awareness Month, a time when communities, organizations, and individuals come together to raise awareness about lung cancer, its risks, and the importance of early detection. In a commendable display of commitment, OncoSwab actively participated in various events during this significant month, making strides in …

OncoSwab involvement in the Lung Cancer Awareness Month Read More »

Founder Pitch Week Spotlight: OncoSwab’s Journey with Bridgette Smith

Founder Pitch Week Spotlight: OncoSwab’s Journey with Bridgette Smith In a world where diversity and inclusion are at the forefront of business conversations, initiatives like Founder Pitch Week have taken center stage, shining a light on the incredible potential of underrepresented founders in the startup ecosystem. OncoSwab, a pioneering company in the field of cancer …

Founder Pitch Week Spotlight: OncoSwab’s Journey with Bridgette Smith Read More »

OncoSwab Takes a Deep Dive into Market Research with I-Corps

OncoSwab Takes a Deep Dive into Market Research with I-Corps” At OncoSwab, our mission has always been to revolutionize cancer diagnostics and improve patient outcomes. We’re committed to staying at the forefront of innovation, which is why we’re excited to announce our participation in the U.S. National Science Foundation’s Innovation Corps (I-Corps) program. This decision …

OncoSwab Takes a Deep Dive into Market Research with I-Corps Read More »

OncoSwab is One of Four Startups selected for DayOne Tech Accelerator

OncoSwab is awarded with the DayOneTech Accelerator Prize We have achieved an extraordinary milestone by being selected as one of only 4 startups awarded the DayOne – Healthcare Innovation Tech Accelerator Prize for groundbreaking medical innovations! This achieves allows us to access to non-dilutive funding, mentorship and be part of the Switzerland Innovation Park in …

OncoSwab is One of Four Startups selected for DayOne Tech Accelerator Read More »

Learn about our journey at the EIT jumpstarter 2023

Learn about our journey at the EIT jumpstarter 2023 EIT Jumpstarter is a pre-accelerator program, meticulously designed and executed by seven communities of the European Institute of Innovation and Technology (EIT). This program spans across nine dynamic categories: health, food, raw materials, energy, urban mobility, manufacturing, digital and a special cohort for Ukrainian innovators. The …

Learn about our journey at the EIT jumpstarter 2023 Read More »

EU TalentOn 2022, learn how OncoSwab started

EU TalentOn 2022: Learn how OncoSwab started https://www.youtube.com/watch?v=tIcHSonsYKM&ab_channel=DNAndrea In September 2022, our team, the “Natural Killers”, embarked on an unforgettable journey at the EU TalentOn Hackathon event in Leiden. Little did we know that our participation would ignite a spark of innovation, leading us to create a groundbreaking solution that would revolutionize cancer detection. This …

EU TalentOn 2022, learn how OncoSwab started Read More »

OncoSwab Joins Health Wildcatters Accelerator Program

OncoSwab Joins Health Wildcatters Accelerator Program OncoSwab, is thrilled to announce its acceptance into the Texas-based Health Wildcatters Accelerator. The renowned program, with a track record of helping healthcare companies (including diagnostics), has been instrumental in shaping healthcare innovators since its establishment in 2013. The accelerator program offers not only seed investment but also a …

OncoSwab Joins Health Wildcatters Accelerator Program Read More »

Rethinking Lung Cancer Screening: Targeting High-Risk Groups

Rethinking Lung Cancer Screening: Targeting High-Risk Groups Lung cancer is a serious illness that affects a lot of people worldwide. Unfortunately, lung cancer is still diagnosed too late, when most people don’t have a very good chance of getting better. This is really concerning, and it means we need to find better ways of catching …

Rethinking Lung Cancer Screening: Targeting High-Risk Groups Read More »

Scroll to Top